Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Lee & Man Paper Manufacturing Ltd. : Share Repurchase

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/06/2013 | 12:45pm CET

For Main Board listed issuers

Next Day Disclosure Return

(Equity issuer - changes in issued share capital and/or share buybacks)

Name of listed issuer: Lee & Man Paper Manufacturing Limited _

Stock code: 2314

Date submitted: _ 6 February 2013

Section I must be completed by a listed issuer where there has been a change in its issued share capital which is discloseable pursuant to rule 13.25A of the Rules (the

"Listing Rules") Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Exchange").

Section II must also be completed by a listed issuer where it has made a repurchase of shares which is discloseable under rule 10.06(4)(a).

Description of securities:

Ordinary shares of HK$0.025_

I.

Issues of shares

(Notes 6 and 7)

No. of shares

Issued shares as a % of

existing issued share

capital before relevant

share issue

(Notes 4, 6 and 7)

Issue price per share

(Notes 1 and 7)

Closing market price

per share of the

immediately preceding

business day

(Note 5)

% discount/ premium of issue price to market price (Note 7)

Opening balance as at

(Note 2)

1 February 2013

4,670,700,000

(Note 3)

Shares repurchased on

21 January 2013, 22 January 2013,

31 January 2013 & 1 February 2013

but not yet cancelled

10,987,000

0.234%

Shares repurchases on 6 February 2013 but not yet cancelled

773,000

0.016%

Closing balance as at

(Note 8)

6 February 2013

4,670,700,000

For Main Board listed issuers
Notes to Section I:
1. Where shares have been issued at more than one issue price per share, a weighted average issue price per share should be given.
2. Please insert the closing balance date of the last Next Day Disclosure Return published pursuant to rule 13.25A or Monthly Return pursuant to rule 13.25B, whichever is the later.
3. Please set out all changes in issued share capital requiring disclosure pursuant to rule 13.25A together with the relevant dates of issue. Each category will need to be disclosed individually with sufficient information to enable the user to identify the relevant category in the listed issuer's Monthly Return. For example, multiple issues of shares as a result of multiple exercises of share options under the same share option scheme or of multiple conversions under the same convertible note must be aggregated and disclosed as one category. However, if the issues resulted from exercises of share options under 2 share option schemes or conversions of 2 convertible notes, these must be disclosed as 2 separate categories.
4. The percentage change in the listed issuer's issued share capital is to be calculated by reference to the listed issuer's total issued share capital (excluding for such purpose any shares repurchased or redeemed but not yet cancelled) as it was immediately before the earliest relevant event which has not been disclosed in a Monthly Return or Next Day Disclosure Return.
5. Where trading in the shares of the listed issuer has been suspended, "closing market price per share of the immediately preceding business day" should be construed as "closing market price per share of the business day on which the shares were last traded".
6. In the context of a repurchase of shares:

"issues of shares" should be construed as "repurchases of shares"; and

"issued shares as a % of existing issued share capital before relevant share issue" should be construed as "repurchased shares as a % of existing issued share capital before relevant share repurchase".

7. In the context of a redemption of shares:

"issues of shares" should be construed as "redemptions of shares";

"issued shares as a % of existing issued share capital before relevant share issue" should be construed as "redeemed shares as a % of existing issued share capital before relevant share redemption"; and

"issue price per share" should be construed as "redemption price per share".

8. The closing balance date is the date of the last relevant event being disclosed.

For Main Board listed issuers

II.

A. Purchase report

Trading date

Number of securities purchased

Method of purchase

(Note)

Price per share or highest

price paid $ Lowest price paid $ Total paid $

06/02/2013 773,000 On the Exchange HK$5.38 HK$5.33 HK$4,144,490

Total 773,000 HK$4,144,490

B. Additional information for issuer whose primary listing is on the Exchange

1. Number of such securities purchased on the Exchange in the year to date (since ordinary resolution)

(a) _30,682,980

2. % of issued share capital at time ordinary resolution passed acquired on the Exchange since date of resolution

( (a) x 100 )

4,689,622,980

_0.654%_

We hereby confirm that the repurchases set out in A above which were made on the Exchange were made in accordance with the Listing Rules and that there have been no

material changes to the particulars contained in the Explanatory Statement dated

28 June 2012

which has been filed with the Exchange. We also confirm that any

purchases set out in A above which were made on another stock exchange were made in accordance with the domestic rules applying to purchases made on that other exchange.

Note to Section II: Please state whether on the Exchange, on another stock exchange (stating the name of the exchange), by private arrangement or by general offer.
For Main Board listed issuers

Submitted by:

Henry Cheung

(Name)

Title:

Company Secretary

(Director, Secretary or other duly authorised officer)

distributed by
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
04:22p MEDOVEX CORP. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)
04:22p Global Solid Tumor Partnering Deals and Agreements by the World's Leading Healthcare Companies 2010 to 2017 - Research and Markets
04:21p FNB NAMIBIA : New investment innovation with 48-hour access from FNB
04:21p DUNDEE PRECIOUS METALS : sets new sulphuric acid target
04:21p S&P 500 MOVERS : Swn, fl
04:19p Patent Issued for Method for Controlling a Contactor Device, and Control Unit (USPTO 9570257)
04:19p HEWLETT PACKARD : US stocks slump as banks and technology companies fall
04:19p ROVSING A/S : Half Year Report 31 December 2016
04:18p OPEC compliance seen growing as laggards Iraq and UAE pledge action
04:18p DTE ENERGY : Foundation grants $15 million to Michigan nonprofits in 2016
Latest news
Advertisement
Hot News 
-4.38%Property website Rightmove generates fewer client leads in 2016
-4.30%VIVENDI : Shares Hit Hard by Fall in Profit -- 2nd Update
-3.11%JUPITER FUND MANAGEMENT : full-year profits hit by rising costs
-2.76%BASF : Profit Boosted by Chemicals Business
-8.53%J.C. Penney reports comp sales drop, to shut 130-140 stores
Most Read News
02:58a SAMSUNG ELECTRONICS : tightens donation rules; report says two group executives offer to quit
02/23 Exclusive - Trump says Republican border tax could boost U.S. jobs
08:33a GM DEMANDS NON-COMPETE CLAUSES IN RETURN FOR OPEL PATENTS : Spiegel
02/23 Safran rejects TCI Fund Management's criticism of Zodiac Aero bid
12:06a TOSHIBA : says it is considering sale of majority stake in chip unit
Most recommended articles
02/23DJVIVENDI : Full-Year Earnings Beat Estimates
10:17a CANADIAN IMPERIAL BANK OF COMMERCE : Canada's Royal Bank hits C$3 billion quarterly profit
10:13a Kraft's shock bid triggers Unilever focus on short-term value
10:12aDJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
10:09a BA owner IAG reports profit rise, share buyback